Myometrial Biopsy for the Detection of Infection
1 other identifier
interventional
1,000
1 country
1
Brief Summary
This study is designed to demonstrate that women in labor become infected without exhibiting any clinical signs or symptoms of infection.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P75+ for not_applicable
Started Jul 2008
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 1, 2008
CompletedFirst Submitted
Initial submission to the registry
October 28, 2008
CompletedFirst Posted
Study publicly available on registry
October 31, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
June 1, 2010
CompletedStudy Completion
Last participant's last visit for all outcomes
July 1, 2010
CompletedOctober 31, 2008
October 1, 2008
1.9 years
October 28, 2008
October 28, 2008
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
Postoperative infection following rupture of amniotic membranes
Amount of time it takes to obtain culture result
Study Arms (2)
Group 1
ACTIVE COMPARATORPatients who have labored and subsequently delivered by cesarean section
2
PLACEBO COMPARATORPatients who electively select cesarean section
Interventions
Eligibility Criteria
You may qualify if:
- Patients must be afebrile throughout labor.
- Patients undergoing an elective cesarean section.
- Patients who have labored with intact or ruptured amniotic membranes.
You may not qualify if:
- Patient with a temperature of ≥ 100.4o F.
- White blood cell count ≥ 24,000.
- Suspicion of chorioamnionitis.
- Suspicion of a urinary tract infection.
- Presence of diarrhea (defined \> 4 liquid stools in a 24 hour period).
- Patient currently taking therapeutic antibiotics.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
The Woman's Hospital of Texas
Houston, Texas, 77054, United States
MeSH Terms
Conditions
Interventions
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Sebastian Faro, MD, PhD
The Woman's Hospital of Texas
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Masking
- NONE
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
October 28, 2008
First Posted
October 31, 2008
Study Start
July 1, 2008
Primary Completion
June 1, 2010
Study Completion
July 1, 2010
Last Updated
October 31, 2008
Record last verified: 2008-10